AR
PRVA icon

Advisory Research’s Privia Health PRVA Stock Holding History

Advisory Research’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,214
Closed -$449K – 472
2023
Q2 		$449K Sell
17,214
-30,827
-64% -$814K 0.06% 301
2023
Q1 		$1.33M Sell
48,041
-6,892
-13% -$182K 0.22% 116
2022
Q4 		$1.25M Sell
54,933
-43,396
-44% -$1.21M 0.12% 127
2022
Q3 		$3.35M Buy
98,329
+11,101
+13% +$411K 0.33% 57
2022
Q2 		$2.54M Buy
+87,228
New +$2.22M 0.25% 72

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Research's PRVA Position: Q3 2023 in Review

Advisory Research sold out of Privia Health (PRVA) in Q3 2023, closing a stake of 17,214 shares — an estimated $449K sold.

Advisory Research first reported a position in PRVA in Q2 2022 and held it in 5 quarters. The position peaked at $3.35M in Q3 2022. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

  • Advisory Research reported no remaining Privia Health position as of Q3 2023 after selling out during the quarter.
  • Advisory Research sold 17,214 Privia Health shares in Q3 2023, an estimated $449K.
  • Advisory Research first reported a position in Privia Health in Q2 2022 and held it in 5 quarters.
  • Advisory Research's Privia Health position peaked at $3.35M in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.